FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387026794> ?p ?o ?g. }

• W4387026794 endingPage "100608" @default.
• W4387026794 startingPage "100608" @default.
• W4387026794 abstract "Despite demonstrating improvements in cardiovascular disease, kidney disease, and survival outcomes, guideline-directed antihyperglycemic medications such as sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like-peptide-1 receptor agonists (GLP1-RA), are underutilized. Many obstacles constrain their use including lack of systematic provider and patient education, concern for medication side effects, and patient affordability.We designed a multimodality, systems-based approach to address these challenges with the goal of increasing medication utilization across the largest healthcare system in New York State. This multispecialty collaborative included provider and patient education, an electronic health record-enabled platform to identify eligible patients, and access to pharmacists for medication guidance and addressing insurance coverage barriers. Surveys were administered following grand rounds lectures and knowledge-based questionnaires were given before and after case-based sessions for housestaff, with results analyzed using a two-sided Student's t-test. Rates of first prescriptions of SGLT2i/GLP1-RA in combined and individual analyses were compared between the pre- and post-education periods (6 months prior to 3/31/2021 and 6 months post 8/19/2021), and the change in prescriptions per 100 eligible-visits was assessed using the incidence density approach.Among grand rounds participants, 69.3% of respondents said they would make changes to their clinical practice. Knowledge increased by 14.7% (p-value <0.001) among housestaff following case-based sessions. An increase in SGLT2i/GLP1-RA prescribing was noted for eligible patients among internal medicine, cardiology, nephrology, and endocrinology providers, from 11.9 per 100 eligible visits in the pre-education period to 14.8 in the post-education period (absolute increase 2.9 [24.4%], incidence risk ratio 1.24 [95% CI 1.18-1.31]; p-value <0.001). Increases in prescribing rates were also seen among individual medical specialties.Our Beyond Diabetes initiative showed an improvement in provider knowledge-base and was associated with a modest, but statistically significant increase in the use of SGLT2i and GLP1-RA throughout our healthcare system." @default.
• W4387026794 created "2023-09-26" @default.
• W4387026794 creator A5001061795 @default.
• W4387026794 creator A5001881788 @default.
• W4387026794 creator A5005074146 @default.
• W4387026794 creator A5012284725 @default.
• W4387026794 creator A5017591400 @default.
• W4387026794 creator A5025680423 @default.
• W4387026794 creator A5035326955 @default.
• W4387026794 creator A5066568879 @default.
• W4387026794 creator A5070847154 @default.
• W4387026794 creator A5078266158 @default.
• W4387026794 creator A5081212824 @default.
• W4387026794 creator A5084970485 @default.
• W4387026794 creator A5086700914 @default.
• W4387026794 creator A5092937723 @default.
• W4387026794 date "2023-12-01" @default.
• W4387026794 modified "2023-10-14" @default.
• W4387026794 title "A System Approach to Improving Guideline-Directed Therapy for Cardio-Renal-Metabolic Conditions: The “Beyond Diabetes” Initiative" @default.
• W4387026794 cites W1993053792 @default.
• W4387026794 cites W2146264128 @default.
• W4387026794 cites W2519510391 @default.
• W4387026794 cites W2712329621 @default.
• W4387026794 cites W2783492123 @default.
• W4387026794 cites W2890802642 @default.
• W4387026794 cites W2894567505 @default.
• W4387026794 cites W2900236147 @default.
• W4387026794 cites W2966117166 @default.
• W4387026794 cites W2968622979 @default.
• W4387026794 cites W2974260792 @default.
• W4387026794 cites W3011650703 @default.
• W4387026794 cites W3020852166 @default.
• W4387026794 cites W3081830235 @default.
• W4387026794 cites W3088173406 @default.
• W4387026794 cites W3096486083 @default.
• W4387026794 cites W3119307884 @default.
• W4387026794 cites W3127371223 @default.
• W4387026794 cites W3177365549 @default.
• W4387026794 cites W3207810076 @default.
• W4387026794 cites W4214667647 @default.
• W4387026794 cites W4220761384 @default.
• W4387026794 cites W4291397630 @default.
• W4387026794 cites W4323293774 @default.
• W4387026794 doi "https://doi.org/10.1016/j.ajpc.2023.100608" @default.
• W4387026794 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37822579" @default.
• W4387026794 hasPublicationYear "2023" @default.
• W4387026794 type Work @default.
• W4387026794 citedByCount "0" @default.
• W4387026794 crossrefType "journal-article" @default.
• W4387026794 hasAuthorship W4387026794A5001061795 @default.
• W4387026794 hasAuthorship W4387026794A5001881788 @default.
• W4387026794 hasAuthorship W4387026794A5005074146 @default.
• W4387026794 hasAuthorship W4387026794A5012284725 @default.
• W4387026794 hasAuthorship W4387026794A5017591400 @default.
• W4387026794 hasAuthorship W4387026794A5025680423 @default.
• W4387026794 hasAuthorship W4387026794A5035326955 @default.
• W4387026794 hasAuthorship W4387026794A5066568879 @default.
• W4387026794 hasAuthorship W4387026794A5070847154 @default.
• W4387026794 hasAuthorship W4387026794A5078266158 @default.
• W4387026794 hasAuthorship W4387026794A5081212824 @default.
• W4387026794 hasAuthorship W4387026794A5084970485 @default.
• W4387026794 hasAuthorship W4387026794A5086700914 @default.
• W4387026794 hasAuthorship W4387026794A5092937723 @default.
• W4387026794 hasBestOaLocation W43870267941 @default.
• W4387026794 hasConcept C126322002 @default.
• W4387026794 hasConcept C134018914 @default.
• W4387026794 hasConcept C142724271 @default.
• W4387026794 hasConcept C159110408 @default.
• W4387026794 hasConcept C160735492 @default.
• W4387026794 hasConcept C162324750 @default.
• W4387026794 hasConcept C177713679 @default.
• W4387026794 hasConcept C2426938 @default.
• W4387026794 hasConcept C2778653478 @default.
• W4387026794 hasConcept C2779134260 @default.
• W4387026794 hasConcept C2780182762 @default.
• W4387026794 hasConcept C50522688 @default.
• W4387026794 hasConcept C512399662 @default.
• W4387026794 hasConcept C54847362 @default.
• W4387026794 hasConcept C555293320 @default.
• W4387026794 hasConcept C71924100 @default.
• W4387026794 hasConceptScore W4387026794C126322002 @default.
• W4387026794 hasConceptScore W4387026794C134018914 @default.
• W4387026794 hasConceptScore W4387026794C142724271 @default.
• W4387026794 hasConceptScore W4387026794C159110408 @default.
• W4387026794 hasConceptScore W4387026794C160735492 @default.
• W4387026794 hasConceptScore W4387026794C162324750 @default.
• W4387026794 hasConceptScore W4387026794C177713679 @default.
• W4387026794 hasConceptScore W4387026794C2426938 @default.
• W4387026794 hasConceptScore W4387026794C2778653478 @default.
• W4387026794 hasConceptScore W4387026794C2779134260 @default.
• W4387026794 hasConceptScore W4387026794C2780182762 @default.
• W4387026794 hasConceptScore W4387026794C50522688 @default.
• W4387026794 hasConceptScore W4387026794C512399662 @default.
• W4387026794 hasConceptScore W4387026794C54847362 @default.
• W4387026794 hasConceptScore W4387026794C555293320 @default.
• W4387026794 hasConceptScore W4387026794C71924100 @default.
• W4387026794 hasFunder F4320307770 @default.
• W4387026794 hasLocation W43870267941 @default.

• next